Improvement of the clinical applicability of tissue-engineered vascular grafts, as new regenerative therapy for children with congenital cardiovascular malformations

Informazioni relative al progetto

LIVAGRAFT

ID dell’accordo di sovvenzione: 626976

Progetto chiuso

Data di avvio 1 Marzo 2014

Data di completamento 29 Febbraio 2016

Finanziato da

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Costo totale € 199 317,60

Contributo UE € 199 317,60

Coordinato da

University of Zurich
Switzerland